Uncategorized
Bausch + Lomb submits NDA for Vesneo
Bausch + Lomb has submitted a new drug application for Vesneo to the FDA, Nicox announced in a press release. Vesneo (latanoprostene bunod ophthalmic solution 0.024%) is a once-daily IOP-lowering single-agent eye drop for patients with open-angle glaucoma or ocular hypertension.